Aptinyx

Developer of small molecules that modulate the NMDA receptor for the treatment of CNS diseases

placeEvanston, Illinois, United States calendar_todayFounded 2015 groups37 employees language aptinyx.com

Registered entities

Innovation

24 patent families (13 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 8,559 times.

YearFilings
20155
20165
20177
201811
201918
20206
202115
202211
20239
20243
20258

Investor mix

24 investors on record; lead investors include Bain Capital, New Leaf Venture Partners; 2 have since exited.

Investor typeCountShare
Venture capital1042%
Private equity833%
Bank & private debt14%
Other / undisclosed521%
Coming soon